Tofacitinib for the treatment of recalcitrant palmoplantar pustulosis: A case report
- 18 July 2019
- journal article
- letter
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 61 (1), e108-e110
- https://doi.org/10.1111/ajd.13117
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Case reportMedicine, 2018
- Successful treatment of palmoplantar pustulosis with rheumatoid arthritis, with tofacitinib: Impact of this JAK inhibitor on T-cell differentiationClinical Immunology, 2016
- IL-1 and IL-36 are the dominant cytokines in Palmar Plantar PustulosisJournal of Dermatological Science, 2016
- IL-8 as Antibody Therapeutic Target in Inflammatory Diseases: Reduction of Clinical Activity in Palmoplantar PustulosisThe Journal of Immunology, 2008